Researchers in Japan are starting human trials for a pioneering drug that stimulates tooth regrowth by inhibiting the US age one protein, allowing bone morphogenetic protein signaling to encourage new teeth growth. Adult males with missing molars will be the initial focus, followed by children with congenital tooth issues. If successful, this drug might be on the market by 2030, potentially transforming dental care and enhancing the lives of millions by addressing tooth loss from various causes.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode